Начало › Остра миелоидна левкемия › Ню Йорк › Buffalo
Клинични проучвания за Остра миелоидна левкемия в Buffalo, NY
19 проучвания за Остра миелоидна левкемия търсят участници в обекти в и около Buffalo (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Набиране на участнициФаза 2
- Roswell Park Cancer Institute, Buffalo
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Набиране на участнициФаза 2
- Roswell Park Cancer Institute, Buffalo
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Набиране на участнициФаза 2
- Roswell Park Cancer Institute, Buffalo
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Набиране на участнициФаза 3
- Roswell Park Comprehensive Cancer Center, Buffalo
Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Набиране на участнициФаза 1
- Roswell Park Cancer Institute, Buffalo
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Набиране на участнициФаза 2
- Roswell Park Cancer Institute, Buffalo
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Набиране на участнициФаза 2
- Roswell Park Cancer Institute, Buffalo
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Набиране на участнициФаза 2
- Roswell Park Cancer Institute, Buffalo
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Набиране на участнициФаза 3
- Roswell Park Cancer Institute, Buffalo
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Набиране на участнициФаза 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Набиране на участнициФаза 3
- State University of New York at Buffalo, Buffalo
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Набиране на участнициФаза 1
- Roswell Park Comprehensive Cancer Center, Buffalo
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
Набиране на участнициФаза 2
- Roswell Park Cancer Institute, Buffalo
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Набиране на участнициНаблюдателно проучване
- Roswell Park Cancer Institute, Buffalo
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Набиране на участнициФаза 2/3
- Roswell Park Comprehensive Cancer Center, Buffalo
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Набиране на участнициФаза 1/2
- Roswell Park Comprehensive Cancer Center, Buffalo
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Набиране на участнициФаза 1
- Roswell Park Comprehensive Cancer Center, Buffalo
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Набиране на участнициФаза 1
- Roswell Park Cancer Institute, Buffalo
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Набиране на участнициФаза 1
- Roswell Park Cancer Institute, Buffalo
Проучвания за Остра миелоидна левкемия в други градове
- Houston, TX85 проучвания
- New York City, NY51 проучвания
- Boston, MA44 проучвания
- Seattle, WA41 проучвания
- Baldwin Park, CA40 проучвания
- Columbus, OH35 проучвания
- Philadelphia, PA34 проучвания
- Durham, NC33 проучвания
- Atlanta, GA31 проучвания
- Tampa, FL29 проучвания
- Chicago, IL26 проучвания
- Portland, OR25 проучвания
Други проучвания в Buffalo
- Рак на белия дроб с недребноклетъчен тип19 проучвания
- Рак (всички видове)19 проучвания
- Рак на белия дроб16 проучвания
- Рак на гърдата16 проучвания
- Рак на яйчниците13 проучвания
- Метастатичен рак11 проучвания
- Рак на простатата11 проучвания
- Меланом10 проучвания
- Множествен миелом10 проучвания
- Затлъстяване9 проучвания
- Лимфом на Бъркит8 проучвания
- Миелодиспластични синдроми8 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.